期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 123, 期 4, 页码 1662-1676出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI65538
关键词
-
资金
- Swiss National Science Foundation [3100A0-113525]
- NCCR Frontiers in Genetics
- European Union
Liver glucose metabolism plays a central role in glucose homeostasis and may also regulate feeding and energy expenditure. Here we assessed the impact of glucose transporter 2 (Glut2) gene inactivation in adult mouse liver (LG2KO mice). Loss of Glut2 suppressed hepatic glucose uptake but not glucose output. In the fasted state, expression of carbohydrate-responsive element-binding protein (ChREBP) and its glycolytic and lipogenic target genes was abnormally elevated. Feeding, energy expenditure, and insulin sensitivity were identical in LG2KO and control mice. Glucose tolerance was initially normal after Glut-2 inactivation, but LG2KO mice exhibited progressive impairment of glucose-stimulated insulin secretion even though beta cell mass and insulin content remained normal. Liver transcript profiling revealed a coordinated downregulation of cholesterol biosynthesis genes in LG2KO mice that was associated with reduced hepatic cholesterol in fasted mice and reduced bile acids (BAs) in feces, with a similar trend in plasma. We showed that chronic BAs or famesoid X receptor (FXR) agonist treatment of primary islets increases glucose-stimulated insulin secretion, an effect not seen in islets from Fxr(-/-) mice. Collectively, our data show that glucose sensing by the liver controls beta cell glucose competence and suggest BAs as a potential mechanistic link.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据